Skip to content
Wednesday, 11 November 2026Malta edition Enquire Malta-24 Briefing @CDNewsDispatch
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch

novartis

Latest 22 January 2026

Vivian Announces Partnership with Novartis Pharma Services AG in Malta

Vivian has entered into a distribution agreement with worldwide R&D pharmaceutical company Novartis Pharma Services AG, a move that continues to reflect Vivian’s established reputation as a trusted partner for…

Coronavirus · 20 Jun 2020 Novartis halts malaria drug trial against COVID-19 Swiss drugmaker Novartis is halting its trial of malaria drug hydroxychloroquine (HCQ) against COVID-19 after struggling to find participants, it said on… USA · 20 Apr 2020 Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with… Coronavirus · 3 Apr 2020 Novartis announces plan to initiate clinical study of Jakavi in severe COVID-19 patients Novartis announced plans to initiate a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi (ruxolitinib) for… Coronavirus · 1 Apr 2020 Novartis donates 20,000 doses of hydroxychloroquine for COVID-19 PEP clinical trial Novartis announced today that it is donating 20,000 doses of hydroxychloroquine to the University of Washington for a COVID-19 PEP clinical trial.… Coronavirus · 30 Mar 2020 Novartis steps up coronavirus fight as part of new collaboration Several big pharmaceutical companies have joined forces with the Bill & Melinda Gates Foundation to scale up solutions and support health systems… Microsoft · 2 Oct 2019 Novartis and Microsoft to develop drugs using AI Swiss pharmaceutical firm Novartis and computer giant Microsoft have signed a five-year partnership deal aimed at transforming the Basel-based pharma’s business -…